PT - JOURNAL ARTICLE AU - Bhattacharya, Arjun AU - Freedman, Anastasia N. AU - Avula, Vennela AU - Harris, Rebeca AU - Liu, Weifang AU - Pan, Calvin AU - Lusis, Aldons J. AU - Joseph, Robert M. AU - Smeester, Lisa AU - Hartwell, Hadley J. AU - Kuban, Karl C.K. AU - Marsit, Carmen J. AU - Li, Yun AU - O’Shea, T. Michael AU - Fry, Rebecca C. AU - Santos, Hudson P. TI - Genetic control of fetal placental genomics contributes to development of health and disease AID - 10.1101/2021.04.12.21255170 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.12.21255170 4099 - http://medrxiv.org/content/early/2021/09/30/2021.04.12.21255170.short 4100 - http://medrxiv.org/content/early/2021/09/30/2021.04.12.21255170.full AB - As the master regulator in utero, the placenta is core to the Developmental Origins of Health and Disease (DOHaD) hypothesis but is historically understudied. To identify placental gene-trait associations (GTAs) across the life course, we performed distal mediator-enriched transcriptome-wide association studies (TWAS) for 40 traits, integrating placental multi-omics from the Extremely Low Gestational Age Newborn Study. At P < 2.5 × 10−6, we detected 248 GTAs, mostly for neonatal and metabolic traits, across 176 genes, enriched for cell growth and immunological pathways. In aggregate, genetic effects mediated by placental expression significantly explained 4 early-life traits but no later-in-life traits. 89 GTAs showed significant mediation through distal genetic variants, identifying hypotheses for distal regulation of GTAs. Investigation of one hypothesis in human placenta-derived choriocarcinoma cells showed that knockdown of mediator gene EPS15 upregulated predicted targets SPATA13 and FAM214A, both associated with waist-hip ratio in TWAS, and multiple genes involved in metabolic pathways. These results suggest profound health impacts of placental genomic regulation in developmental programming across the life course.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by grants from the National Institutes of Health (NIH), specifically the National Institute of Neurological Disorders and Stroke (U01NS040069; R01NS040069), the Office of the NIH Director (UG3OD023348), the National Institute of Environmental Health Sciences (T32-ES007018; P30ES019776; R24ES028597), the National Heart, Lung and Blood Institute (R01HL47883, R01HL148577), the National Institute of Nursing Research (K23NR017898; R01NR019245), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD092374; R03HD101413; P50HD103573).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institutional Review Board of the University of North Carolina at Chapel Hill. All participants consented to the study as per IRB protocol.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCODE AVAILABILITY Sample scripts for analysis are provided at https://github.com/bhattacharya-a-bt/dohad_twas. The MOSTWAS software is accessible at https://bhattacharya-a-bt.github.io/MOSTWAS/articles/MOSTWAS_vignette.html. DATA AVAILABILITY ELGAN mRNA, miRNA, and CpG methylation data can be accessed from the NCBI Gene Expression Omnibus GSE154829 and GSE167885. ELGAN genotype data is protected, as subjects are still enrolled in the study; any inquiries or data requests must be made to RCF and HPS. GWAS summary statistics can be accessed at the following links: UK Biobank (http://www.nealelab.is/uk-biobank), GIANT consortium (https://portals.broadinstitute.org/collaboration/giant/index.php/Main_Page), PGC (https://www.med.unc.edu/pgc/download-results/), EGG consortium (https://egg-consortium.org/), and CTG Lab (https://ctg.cncr.nl/software/). The RICHS eQTL dataset can be accessed via dbGaP accession number phs001586.v1.p1 (https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001586.v1.p1). Placental epigenomic annotations from the ENCODE Project are available from https://www.encodeproject.org/, with specific accession numbers in Supplemental Table S13. All models and full TWAS results can be accessed at https://doi.org/10.5281/zenodo.4618036121. RNA-seq data generated in placental JEG-3 cells are available at GSE185071. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE154829 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE167885 http://www.nealelab.is/uk-biobank https://portals.broadinstitute.org/collaboration/giant/index.php/Main_Page https://www.med.unc.edu/pgc/download-results/ https://egg-consortium.org/ https://ctg.cncr.nl/software/ https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001586.v1.p1 https://www.encodeproject.org/ https://elgan-twas.shinyapps.io/dohad/